These stocks are usually going up or down because of brokers upgraded or downgraded .If you are looking to day trade, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels.You can also check previous stocks to buy reports- Right Here.
ViroPharma (VPHM), CME Group (CME), Juniper (JNPR), VMware (VMW), Boston Scientific (BSX), VIVUS (VVUS), Potash (POT) were upgraded or downgraded by analysts.
ViroPharma (VPHM) initiated with a Buy at Brean Murray Target $37.
CME Group (CME) upgraded to Outperform from Neutral at Macquarie.Macquarie believes the impact from MF Global on CME Group's volumes will prove temporary and that valuation is attractive given lowered expectations and EPS growth. Price target is $344.
Juniper (JNPR) upgraded to Outperform from Market Perform at BMO Capital.BMO Group upgraded Juniper Networks based on lowered expectations and 1H 2012 capex improvement. Price target raised to $25 from $22.
VMware (VMW) upgraded to Buy from Hold at Wunderlich.Wunderlich upgraded VMware with a $95 price target citing a compelling risk/reward profile at current levels.
Boston Scientific (BSX) downgraded to Neutral from Buy at Mizuho
Price target cut to $5.40 from 47.
VIVUS (VVUS) downgraded to Neutral from Buy at Roth Capital.Roth Capital downgraded Vivus due to arbitrary FORTRESS data results. Price target is $11.50.
Potash (POT) upgraded to Outperform from Sector Perform at RBC Capital.RBC Capital lowered its fertilizer price forecasts but upgraded Potash based on valuation. Price target lowered to $50 from $58
CME Group (CME) upgraded to Outperform from Neutral at Macquarie.Macquarie believes the impact from MF Global on CME Group's volumes will prove temporary and that valuation is attractive given lowered expectations and EPS growth. Price target is $344.
Juniper (JNPR) upgraded to Outperform from Market Perform at BMO Capital.BMO Group upgraded Juniper Networks based on lowered expectations and 1H 2012 capex improvement. Price target raised to $25 from $22.
VMware (VMW) upgraded to Buy from Hold at Wunderlich.Wunderlich upgraded VMware with a $95 price target citing a compelling risk/reward profile at current levels.
Boston Scientific (BSX) downgraded to Neutral from Buy at Mizuho
Price target cut to $5.40 from 47.
VIVUS (VVUS) downgraded to Neutral from Buy at Roth Capital.Roth Capital downgraded Vivus due to arbitrary FORTRESS data results. Price target is $11.50.
Potash (POT) upgraded to Outperform from Sector Perform at RBC Capital.RBC Capital lowered its fertilizer price forecasts but upgraded Potash based on valuation. Price target lowered to $50 from $58
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
